Answers are grounded in this paper and cite their sources.
Quantifies changes in pain sensitivity in mice using transcutaneous optogenetic stimulation, indicating methodological advancements for pain research.
Optogenetics provides an unprecedented opportunity to delineate how different somatosensory afferents contribute to sensation, including pain. Afferents expressing channelrhodopsin-2 (ChR2) can be selectively activated by transcutaneous photostimuli applied to behaving mice. Despite targeting expression of ChR2 to specific cell types, imprecise photostimulation has hindered quantitative optogenetic-based behavioral testing. Here, we used a robot to reproducibly apply transcutaneous optogenetic stimuli to the hind paw of mice while measuring nocifensive withdrawal. Different photostimulus waveforms (pulses and ramps) and response metrics (threshold and latency) were compared in mice of either sex expressing ChR2 in all afferents (Advillin-ChR2) or preferentially in nociceptors (Na V 1.8-ChR2). Inflammation induced by complete Freund’s adjuvant (CFA) caused withdrawal from ramped photostimuli to become faster relative to baseline and to vehicle-injected controls whereas pulsed photostimuli revealed a modest increase in threshold. Analgesia caused by Na V 1.7 and 1.8 channel blockade was evident in both testing protocols. Overall, ramp-based testing was more effective and more efficient (i.e. required less time and total stimulation) than pulse-based testing. Electrophysiological measurements confirmed that CFA increases nociceptor excitability without affecting phototransduction, suggesting that withdrawal latency depends on the number of nociceptors activated rather than how strongly each nociceptor is activated. Consistent with changes described in nociceptor somata, the behavioral consequences of peripherally blocking different voltage-gated sodium (Na V ) channels showed that nociceptor axons normally rely on Na V 1.8 but upregulate Na V 1.7 after CFA, with important clinical implications for drug efficacy. Collectively, these results demonstrate the utility of optogenetic pain testing when reproducibly delivered and strategically designed photostimuli are used. Significance statement Transcutaneous optogenetic stimulation in behaving mice has been used for over a decade to help delineate the contribution of various types of somatosensory afferents to sensation, especially pain. Such testing has typically involved applying light pulses via handheld fiber optic cables and scoring withdrawal responses by eye, but more quantitative testing is now possible thanks to new technology enabling reproducible photostimulation and precise withdrawal measurement. Our comparison of optogenetic pulse-based threshold measurements and ramp-based latency measurements shows the latter is better suited for measuring inflammation-induced hypersensitivity. We also demonstrate the utility of ramp-based latency measurements for quantifying analgesia by Na V channel blockade. Links between the excitability of channelrhodopsin-expressing afferents and optogenetically evoked paw withdrawal are also highlighted.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: